Oslo-based startup Dr.Dropin has raised 19 million euros from German venture capital firms SHS Capital and yabeo. The round also saw participation from its existing investors Andenes Ventures and Stenshagen Invest. The Norwegian provider of healthcare services enables short-term medical consultation and treatment – in person on site as well as digitally via app. The startup will use the funding to expand internationally and focus on product development.
SHS and yabeo invest in the leading Scandinavian digital health platform Dr.Dropin
The Tübingen-based investment company SHS invests together with the Munich-based investor yabeo in Dr.Dropin, a digital + physical healthcare provider platform for medical consultations – physically on site at one of the Dr.Dropin clinics or in the form of a digital consultation via app.
In times of the corona pandemic, but also before, patients suffer from long waiting times until they get an appointment with a doctor. Independent it is an appointment with a general practitioner or a specialist – the waiting times are long and the patient journeys often challenging. Dr.Dropin would like to eliminate these difficulties with its bundle of clinics. Appointments are easily booked online via the company’s own app. Patients should thus be able to be treated at short notice without long waiting times either in person or via digital consultation hours. Follow-up appointments can also take place easily within the digital set-up.
In this way, Dr.Dropin combines the personal contact that is essential in medical consultations with the advantages digital products have in order to make patients’ journeys easier in their everyday lives.
As part of the investment strategy, Dr.Dropin wants, based on the success in Norway, to expand its services into other European countries. SHS supports the company in its expansion and sees Dr. Dropin’s patient offering as a competitive advantage that promises great growth potential.
“We are delighted to have SHS on board on our exciting journey towards internationalisation and to have an investor with sector expertise and vision. Our goal is to make healthcare better and easily accessible to everyone,” says Dr.Dropin CEO Daniel Sørli.
“SHS is pleased to be able to support a company like Dr.Dropin. Nowadays, a straightforward and fully comprehensive medical offer with the possibility of digital consultation is essential. We think that Dr.Dropin’s ‘digiphysical’ concept fills a promising gap in the market and we are pleased to be able to support the company with our know-how and many years of experience in the healthcare sector.
We are always seeking for promising companies that have the potential to become European healthcare champions like Dr.Dropin,” explains SHS partner Dr. Cornelius Maas.
Dr. Gerrit Seidel, Managing Director, and Partner at Yabeo comments: “We are always looking for innovative and disruptive healthtech companies to invest in, and Dr.Dropin fits our profile well.
With the growth and development shown by Dr.Dropin and their highly dedicated team so far, combined with our goal of investing in companies that are game changers within their industry, we believe this transaction will contribute to Dr.Dropins competitive growth when entering the European markets”.